✦ LIBER ✦

Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning

✍ Scribed by Martee L. Hensley; Denise D. Correa; Howard Thaler; Andrew Wilton; Ennapadam Venkatraman; Paul Sabbatini; Dennis S. Chi; Jakob Dupont; David Spriggs; Carol Aghajanian

Book ID: 113960445
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 261 KB
Volume: 102
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2005.12.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of carboplatin followed b

Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

A phase II feasibility study of carbopla

A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer

✍ Harries, M; Moss, C; Perren, T; Gore, M; Hall, G; Everard, M; A'Hern, R; Gibbens 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

A phase II study of weekly carboplatin a

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer: A Multicentre Italian Trial in Ovarian cancer (MITO-5) study

✍ Sandro Pignata; Enrico Breda; Giovanni Scambia; Carmela Pisano; Vittorina Zagone 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Interferon-gamma in combination with car

Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study

✍ C. MARTH; G.H. WINDBICHLER; H. HAUSMANINGER; E. PETRU; K. ESTERMANN; A. PELZER; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB